Assets: The family's 75% of Merck KGaA is split among nearly 100 family members.
So is a cancer vaccine from Oncothyreon and Merck KGaA, the German Merck.
Novartis just got an additional gift as a rival drug cladribine from Merck KgaA was rejected by European regulators.
FORBES: From Cicada Fungus To MS Drug: How Big Will Novartis' New Pill Be?
That same month pharmaceutical maker Merck KGaA of Germany agreed to co-develop with Chi-Med anticancer drugs derived from natural products.
The second vaccine to watch, Cheever says, comes from biotech Oncothyreon of Seattle, which is collaborating with Merck KgaA of Germany.
Schering AG and Merck KgAA were separated from Schering-Plough (nyse: SGP - news - people ) of Kenilworth, N.
Merck KGaA, for instance, is developing an MS pill called cladribine.
Merck KGaA gave the index a boost, adding 4.2% after it raised its outlook for full-year earnings and after revenue in the second quarter rose 12%.
Facebook "has not been cooperative" in restoring the page, and in several alleged communications appeared nonresponsive or evasive in dealing with Merck KGaA, the filing added.
Merck KGaA, which is distinct from the U.S. company of the same name, will use this new data to try to get Erbitux approved in Europe.
"We just want details about how our URL was taken over by the company and we are wondering why this happened, " a spokesman for Merck KGaA said Thursday.
Now, he has sold his family's controlling share of the company to German drug giant Merck KGaA. And one of biotech's most colorful characters may be a little less visible.
Merck KGaA , which has the rights to sell Erbitux in Europe, conducted the new trials, which were presented at the annual meeting of the American Society of Clinical Oncology in Chicago.
The new application is similar to the previous one that the Food and Drug Administration refused to consider, insiders say--but with the crucial addition of positive new trial results from Germany's Merck KGaA .
Like Bayer, Merck KgAA wanted Schering's pipeline, profitability and relatively large U.S. presence--and to create a drug firm big enough to compete with the likes of Pfizer (nyse: PFE - news - people ), GlaxoSmithKline (nyse: GSK - news - people ) and Sanofi-Aventis .
That same month pharmaceutical maker Merck (nyse: MRK - news - people ) KGaA of Germany agreed to co-develop with Chi-Med anticancer drugs derived from natural products.
应用推荐